Summary
An ultrastructural and immunocytochemical study was undertaken to elucidate the temporal and quantitative aspects of the changes occurring in the delta cells in the pancreatic islets of C57BL/KsJdb/db (diabetes) mice. Electron microscopy revealed that prior to the major topographical redistribution of delta cells from their peripheral location to the islet interior, long delta cell filopodial extensions penetrated into the islet, greatly increasing the area of surface contact between delta cells and hypersecretory beta cells. Coincident with delta cell redistribution in islets of 8 to 10 week diabetes mice, the mean number of delta cells per islet had increased significantly. In contrast, their volume density had decreased, indicating incomplete compensation for beta cell hyperplasia which had commenced approximately 4 weeks earlier. In the 14 week mutants, numbers of delta cells per islet and islet volume reached maximum values while delta cell volume density had been restored to a control level. Delta cell volume density exhibited a 2-fold increase in the mutants at 20 weeks that coincided with massive beta cell necrosis. However, a decline in the number of delta cells per islet (173.6±20.9 at 14 weeks versus 91.2±9.5 at 20 weeks) suggests that islet degeneration in terminal stages of the syndrome also includes some loss of these cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alberti, K. G. M. M., Christensen, N. J., Christensen, S. E., Hansen, A. P., Iversen, J., Lundbaek, K., Seyer-Hansen, K., Ørskov, H.: Inhibition of insulin secretion by somatostatin. Lancet1973 II, 1299–1301
Baetens, D., Stefan, Y., Ravazzola, M., Malaisse-Lagae, F., Coleman, D. L., Orci, L.: Alteration of islet cell populations in spontaneously diabetic mice. Diabetes27, 1–7 (1978)
Coleman, D. L.: Obesity and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia14, 141–148 (1978)
Coleman, D. L., Hummel, K. P.: Studies with the mutation, diabetes, in the mouse. Diabetologia3, 238–248 (1967)
Coleman, D. L., Hummel, K. P.: Hyperinsulinemia in preweaning diabetes(db) mice. Diabetologia10, 607–610 (1974)
Dubois, M. P.: Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas. Proc. Natl. Acad. Sci. USA74, 2140–2143 (1975)
Dubois, P. M., Paulin, C., Assan, R., Dubois, M. P.: Evidence for immunoreactive somatostatin in the endocrine cells of the human fetal pancreas. Nature256, 731–732 (1975)
Fujimoto, W. J., Ensinck, J. W., Williams, R. H.: Somatostatin inhibits insulin and glucagon release by monolayer cell cultures of rat endocrine pancreas. Life Sci.15, 1999–2004 (1974)
Fujita, T., Yanatori, Y., Murakami, T.: Insulo-acinar axis, its vascular basis and its functional and morphological changes caused by CCK-PZ and caerulein. In: Endocrine gut and pancreas. Fujita, T. (Ed.), pp. 347–357. Amsterdam: Elsevier 1976
Gerich, J. E., Lovinger, R., Grodsky, G. M.: Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol, and theophylline: Evidence for a peripheral effect on glucagon secretion. Endocrinology96, 749–754 (1975)
Goldsmith, P. C., Rose, J. C., Arimura, A., Ganong, W. F.: Ultrastructural localization of somatostatin in pancreatic islets of the rat. Endocrinology97, 1061–1064 (1975)
Holt, W. V., Healy, P.: The use of an image analyzer for measuring the cross-sectional area of Leydig cells in the testis of the cuis. Mikroskopie32, 76–80 (1976)
Hopkins, B. M.: A quantitative image analysis system. Opt. Eng.15, 236–240 (1976)
Hummel, K. P., Coleman, D. L., Lane, P. W.: The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL/KsJ and C57BL/6J strains. Biochem. Genet.7, 1–13 (1972)
Ipp, E., Dobbs, R., Orci, L., Vale, W., Unger, R. H.: Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymincholecystokinin, and tolbutamide. J. clin. Invest.60, 760–765 (1977)
Koerker, D. J., Ruch, W., Chideckel, E., Palmer, J., Goodner, C. J., Ensinck, J., Gale, C. C.: Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science184, 482–484 (1974)
Leiter, E. H., Coleman, D. L., Eppig, J. J.: Endocrine pancreatic cells of postnatal “diabetes”(db) mice in cell culture. In vitro15, 507–521 (1979)
Like, A. A., Chick, W. L.: Studies in the diabetic mutant mouse. I. Light microscopy and radioautography of pancreatic islets. Diabetologia6, 207–215 (1970)
Like, A. A., Chick, W. L.: Studies in the diabetic mutant mouse. II. Electron microscopy of pancreatic islets. Diabetologia6, 216–242 (1970)
Marco, J., Hedo, J. A., Villaneueva, M. L.: Inhibitory effect of somatostatin on human pancreatic polypeptide secretion. Life Sci.21, 789–792 (1977)
McEvoy, R. C., Hegre, O. D.: Morphometric quantitation of the pancreatic insulin-, glucagon-, and somatostatin-positive cell populations in normal and alloxan-diabetic rats. Diabetes26, 1140–1146 (1977)
Mortimer, C. H., Tunbridge, W. G. M., Carr, D., Yeomans, L., Lind, T., Coy, D. H., Bloom, S. R., Kastin, A., Mallinson, C. N., Besser, G. M., Schally, A. V., Hall, R.: Effects of growth hormone release-inhibiting hormone in circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet1974 I, 697–701
Orci, L.: The microanatomy of the islets of Langerhans. Metabolism25 (Suppl. 1), 1303–1314 (1976)
Orci, L., Unger, R. H.: Hypothesis: Functional subdivisions of islets of Langerhans and possible roles of D-cells. Lancet1975 II, 1243–1244
Orci, L., Baetans, D., Dubois, M. P., Rufener, C.: Evidence for the D-cell of the pancreas secreting somatostatin. Horm. Metab. Res.7, 400–402 (1975)
Orci, L., Amherdt, M., Henquin, J. C., Lambert, A. E., Unger, R. H., Renold, A. E.: Pronase effect on pancreatic beta cell secretion and morphology. Science180, 647–649 (1973)
Orci, L., Baetens, D., Rufener, C., Amherdt, M., Ravazzola, M., Studer, P., Malaisse-Lagae, F., Unger, R. H.: Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc. Natl. Acad. Sci. USA73, 1338–1342 (1976)
Patton, G. S., Dobbs, R., Orci, L., Vale, W., Unger, R. H.: Stimulation of pancreatic immunoreactive somatostatin (IRS) release by glucagon. Metabolism25 (Suppl. 1), 1499 (1976)
Sternberger, L. A., Handy, P. H., Cuculis, J. J., Meyer, H. C.: An unlabeled antibody method of immunocytochemistry. J. Histochem. Cytochem.18, 315–340 (1970)
Turcot-Lemay, L., Lemay, A., Lacy, P. E.: Somatostatin inhibition of insulin release from freshly isolated and organ cultured rat islets of Langerhans in vitro. Biochem. Biophys. Res. Commun.63 1130–1138 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leiter, E.H., Gapp, D.A., Eppig, J.J. et al. Utrastructural and morphometric studies of delta cells in pancreatic islets from C57BL/Ks diabetes mice. Diabetologia 17, 297–309 (1979). https://doi.org/10.1007/BF01235886
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01235886